NCT01990014

Brief Summary

The objective of this protocol is to evaluate the quality of life and functional disability in the long term (2 years after craniectomy) in subject's victims of malignant Sylvien stroke who received a decompressive craniotomy in the acute phase. Patients who have given their consent to be evaluated at least two years after their stroke and their operation in a single visit by clinical examination and procurement of standardized scales. Will be measured the quality of life through scale SIS3.0, residual disability by the Rankin scale. The quality of life of the carer will be assessed through scales and Zarit carer version of SIS3.0. The existence of predictive parameters of long-term evolution will be searched in determining the existence of a correlation between demographic data and baseline characteristics of the stroke on and the evolution of the quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2011

Typical duration for all trials

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 25, 2013

Completed
27 days until next milestone

First Posted

Study publicly available on registry

November 21, 2013

Completed
Last Updated

September 10, 2021

Status Verified

September 1, 2021

Enrollment Period

1.7 years

First QC Date

October 25, 2013

Last Update Submit

September 8, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • To assess the quality of life for long-term patients victims of malignant sylvian ischemic stroke who received decompressive craniectomy.

    at least two years

Secondary Outcomes (7)

  • To evaluate the quality of life in the physical and psychosocial domains

    at least two years

  • To evaluate the evolution of functional disability

    At 3 months, 12 months and 24 months.

  • To evaluate the life satisfaction

    at least two years

  • To assess the rate of recovery work

    at least two years

  • To evaluate the retrospective review of patients achieving craniectomy

    at least two years

  • +2 more secondary outcomes

Study Arms (1)

craniectomy

Adult subjects who experienced a cerebral infarction extended the sylvian area, and having received treatment by decompressive craniectomy.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult subjects who experienced a cerebral infarction extended the sylvian area, and having received treatment by decompressive craniectomy.

You may qualify if:

  • Age\> = 18 years
  • Having presented an ischemic stroke involving the sylvian area
  • Having received decompressive craniectomy in acute ischemic stroke
  • Signed informed consent
  • Patient affiliated to a social security system

You may not qualify if:

  • Patients with a Rankin score before stroke than or equal to 3
  • Stroke in multiple territories (contralateral carotid and / or vertebrobasilar) associated with stroke in the acute phase describing which in the opinion of the investigator significantly influence the long-term functional prognosis
  • Cognitive deterioration or severe aphasia making it impossible to fill out questionnaires
  • Minors
  • Major under curators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

CHU Angers

Angers, France

Location

CHU de Brest

Brest, France

Location

CH R U Pontchaillou

Rennes, France

Location

CHU Bretonneau

Tours, France

Location

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • SÉVIN ALLOUET Mathieu, Dr

    Nantes University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2013

First Posted

November 21, 2013

Study Start

June 1, 2011

Primary Completion

February 1, 2013

Study Completion

July 1, 2013

Last Updated

September 10, 2021

Record last verified: 2021-09

Locations